Effect of riceberry rice consumption on metabolic responses and body composition in obese children and adolescents

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20230815002

Enrollment

Registered

2023-08-15

Start date

2023-09-22

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children and adolescents with exogenous obesity that is defined by BMI-for-age z-score at median+2SD and above Pediatric obesity, rice, dyslipidemias, body composition

Interventions

Administer 150 g of riceberry rice per day with lifestyle modification.,Administer 150 g of white rice per day with lifestyle modification.

Experimental Dietary Supplement,Placebo Comparator Dietary Supplement

Riceberry rice,White rice

Eligibility

Sex/Gender

All

Age

10 Years to 17 Years

Inclusion criteria

Inclusion criteria: 1. WHO BMI-for-age z-score greater than median+2SD 2. Diagnosed with exogenous obesity 3. Achieve consent from parents for blood sampling and assessment of body composition 4. Agree to document food record and be followed up through regular phone calls

Exclusion criteria

Exclusion criteria: 1. Pathological obesity 2. Presence of other co-morbidities not related to exogenous obesity 3. Diagnosed with Blount's disease or slipped capital femoral epiphysis 4. Diagnosed with diabetes mellitus 5. Allergic to riceberry rice or white rice 6. Receive medication that intefere with blood glucose and lipid profiles 7. Smoking 8. Presence of visual or hearing impairment 9. Inability to understand Thai language

Design outcomes

Primary

Measure	Time frame
lipid profiles 0 and 6 weeks plasma lipid levels	—

Secondary

Measure	Time frame
Changes in weight, height, and BP 0 and 6 weeks weighing scale, stadiometer, sphygmomanometer,Changes in body composition 0 and 6 weeks BIA and DEXA,Markers of inflammation, oxidative stress, anti-oxidant capacity, adipokines, and hepcidin 0 and 6 weeks blood analysis,Changes in blood glucose and insulin 0 and 6 weeks Blood analysis,Anthocyanins consumption from rice random sampling throughout intervention period pH-differential method,Association of anthocyanins consumption and markers of inflammation, oxidative stress, anti-oxidant capacity, adipokines, and hepcidinchanges in throughout intervention period (anthocyanins); 0 and 6 weeks (markers) pH-differential method and blood analysis,Body composition 0 and 6 weeks BIA vs DEXA	—

Measure

Time frame

Changes in weight, height, and BP 0 and 6 weeks weighing scale, stadiometer, sphygmomanometer,Changes in body composition 0 and 6 weeks BIA and DEXA,Markers of inflammation, oxidative stress, anti-oxidant capacity, adipokines, and hepcidin 0 and 6 weeks blood analysis,Changes in blood glucose and insulin 0 and 6 weeks Blood analysis,Anthocyanins consumption from rice random sampling throughout intervention period pH-differential method,Association of anthocyanins consumption and markers of inflammation, oxidative stress, anti-oxidant capacity, adipokines, and hepcidinchanges in throughout intervention period (anthocyanins); 0 and 6 weeks (markers) pH-differential method and blood analysis,Body composition 0 and 6 weeks BIA vs DEXA

—

Countries

Thailand

Contacts

Public ContactNarumon Densupsoontorn

Faculty of Medicine Siriraj Hospital, Mahidol University

narumon.den@mahidol.ac.th024195947

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026